Form Type: 4

SEC EDGAR Link
Accession Number:0000899243-21-026817
Date:2021-06-29
Issuer: VINCERX PHARMA, INC. (VINC)
Original Submission Date:

Reporting Person:

SEELENBERGER ALEXANDER A.
260 SHERIDAN AVENUE, SUITE 400
PALO ALTO, CA 94306

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-06-29 P 7,950 a $12.61 7,950 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 represents a weighted average purchase price. actual purchase prices ranged from $12.56 to $12.69 per share. reporting person undertakes to provide upon request by the securities and exchange commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares purchased within the range indicated.
WhaleWisdom Logo

Elevate your investments